ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.

Benjamin H Lok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.